Read on Twitter
1/15
In addition to all of that, there's this whole #ABDX capacity expansion debate.
The Admission Doc was clear, as was the webinar presentation.
"Manufacturing capacity 1m tests per week by year end 2020."
https://twitter.com/BigBiteNow/status/1361268214727122946?s=20
In addition to all of that, there's this whole #ABDX capacity expansion debate.
The Admission Doc was clear, as was the webinar presentation.
"Manufacturing capacity 1m tests per week by year end 2020."
https://twitter.com/BigBiteNow/status/1361268214727122946?s=20
2/
The message in the webinar, which in essence regurgitated much of the Admission Doc, was that whilst clean rooms etc were in place, equipment was required to achieve the expansion upgrade, with no physical figs. given on exactly where they were at that point in time.
The message in the webinar, which in essence regurgitated much of the Admission Doc, was that whilst clean rooms etc were in place, equipment was required to achieve the expansion upgrade, with no physical figs. given on exactly where they were at that point in time.
3/
Given we are talking an IPO Admission Doc (which was dated Dec 2020 and the facts involved are about capacity, which is the bread and butter of the operation and expansion thereof, was why they did the IPO and raised £20m along with it), one would expect that the Dec 2020...
Given we are talking an IPO Admission Doc (which was dated Dec 2020 and the facts involved are about capacity, which is the bread and butter of the operation and expansion thereof, was why they did the IPO and raised £20m along with it), one would expect that the Dec 2020...
4/
target of 1m was very much on and if there was a problem, then it would have been adjusted.
However, if it was too late to adjust said fig, due to going to print, then 2 months later, in the webinar, the opportunity was there to rectify this, or at the very least, soften...
target of 1m was very much on and if there was a problem, then it would have been adjusted.
However, if it was too late to adjust said fig, due to going to print, then 2 months later, in the webinar, the opportunity was there to rectify this, or at the very least, soften...
5/
the expectation, if it wasn't actually going to happen until April. After all, its not a good start to your life in the public eye, if you double down on figs, that actually won't be achieved until some 3 months later.
It is however still very possible that this is the case,
the expectation, if it wasn't actually going to happen until April. After all, its not a good start to your life in the public eye, if you double down on figs, that actually won't be achieved until some 3 months later.
It is however still very possible that this is the case,
6/
which would have to be questioned with N1-Singer and ABDX themselves.
However, like so many of the players involved in this Uk diagnostics push, April is a key date in their calendar because its the Uk Gov date for their 2m/per day LFT target.
which would have to be questioned with N1-Singer and ABDX themselves.
However, like so many of the players involved in this Uk diagnostics push, April is a key date in their calendar because its the Uk Gov date for their 2m/per day LFT target.
7/
A target which if indeed true, can only be achieved by all of those players, lending as much of a hand as possible.
The FT article suggested that ODX, Surescreen and GAD, are involved.
Since then #ODX are confirmed and with it their "end of April..." https://www.ft.com/content/37011547-c7b1-403b-abfd-9b3e554fb4b2
A target which if indeed true, can only be achieved by all of those players, lending as much of a hand as possible.
The FT article suggested that ODX, Surescreen and GAD, are involved.
Since then #ODX are confirmed and with it their "end of April..." https://www.ft.com/content/37011547-c7b1-403b-abfd-9b3e554fb4b2
8/
2m tests per week capacity expansion.
The FT article reported that GAD are due to hit 250m tests per annum, by early May, helped along by "about £10m in equipment" from the UK Gov.
#AVCT, on the very same day that the FT article and UK Gov announcement of their contract...
2m tests per week capacity expansion.
The FT article reported that GAD are due to hit 250m tests per annum, by early May, helped along by "about £10m in equipment" from the UK Gov.
#AVCT, on the very same day that the FT article and UK Gov announcement of their contract...
9/
Surescreen came along, announced their tie up with Mologic (which clearly isn't recent, given that Dr Smith later revealed, that Mologic is ready to produce the test. So tech transfer is complete?) and a end of Q1, so April, CE mark target and launch.
Surescreen came along, announced their tie up with Mologic (which clearly isn't recent, given that Dr Smith later revealed, that Mologic is ready to produce the test. So tech transfer is complete?) and a end of Q1, so April, CE mark target and launch.
10/ I suspect if we had access, then we would find out that BBI are heading for the exact same target.
Furthermore, ABDX CEP Chris Yates confirmed in the Q&A, that he had been part of the calls involving the UK rapid antigen test consortium.
Dr Smith from AVCT, confirmed...
Furthermore, ABDX CEP Chris Yates confirmed in the Q&A, that he had been part of the calls involving the UK rapid antigen test consortium.
Dr Smith from AVCT, confirmed...
11/
that "fortunately now there is a collaborative group of UK companies," which includes "test manufacturers such as GAD and BBI."
If BBI are in the picture, then so must Abingdon Health be also. https://twitter.com/BigBiteNow/status/1358773890802200576?s=20
that "fortunately now there is a collaborative group of UK companies," which includes "test manufacturers such as GAD and BBI."
If BBI are in the picture, then so must Abingdon Health be also. https://twitter.com/BigBiteNow/status/1358773890802200576?s=20
12/
I believe there's more than enough warrant to be backing ABDX at these levels, even if they only strive to fulfill, their own contracts, under their own steam and a healthy portion of that, is riding the success of a AVCT test, outside of UK Gov.
I believe there's more than enough warrant to be backing ABDX at these levels, even if they only strive to fulfill, their own contracts, under their own steam and a healthy portion of that, is riding the success of a AVCT test, outside of UK Gov.
13/
However, if ever there was ever smoke with fire, then its centred around this highly secretive Uk Gov exercise, to push significant daily LFT availability.
So despite ABDX CEO Chris Yates, selling the story of waiting on equipment, be it their or someone else's,
However, if ever there was ever smoke with fire, then its centred around this highly secretive Uk Gov exercise, to push significant daily LFT availability.
So despite ABDX CEO Chris Yates, selling the story of waiting on equipment, be it their or someone else's,
14/
i struggle to take that at face value, given the smoke and mirrors going on all over the UK diagnostics industry, right now.
Despite all of that, I am still factoring in 1m a week production by April 2021 and that's absolutely fine because more should come.
But!
i struggle to take that at face value, given the smoke and mirrors going on all over the UK diagnostics industry, right now.
Despite all of that, I am still factoring in 1m a week production by April 2021 and that's absolutely fine because more should come.
But!
15/
the X factor remains the chance that it could well be much more than that, which acts as a significant bonus, to everything else that is in play with ABDX right now.
the X factor remains the chance that it could well be much more than that, which acts as a significant bonus, to everything else that is in play with ABDX right now.
